Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Here are the seven latest drugs or medical devices approved by the Food and Drug Administration since Aug. 18.
In a recent press release, Resource Optimization & Innovation (ROi) announced that it has completed its acquisition of Orlando-based Healthcare Purchasing Alliance, LLC (HPA), a member-driven organization dedicated to providing clinical quality and cost savings through health care group purchasing…
Here are seven articles published by Becker's Hospital Review in the last week, detailing Gilead Science's $12B takeover of Kite Pharma, the approval of Novartis' revolutionary leukemia drug and more.
A South Carolina couple filed a proposed class action lawsuit against Amazon Tuesday, claiming faulty solar eclipse glasses they purchased from the online retailer gave them eye damage, reports Reuters.
Novartis will partner with CMS to offer an outcomes-based pricing model for its new leukemia drug Kymriah.
The FDA approved Novartis' revolutionary CAR-T cell leukemia therapy, which uses patients' genetically modified immune cells to fight the disease — at the cost of $475,000 per treatment, according to STAT.
The Food and Drug Administration this month granted breakthrough designation to a Santa Cruz, Calif.-based nonprofit's MDMA therapy for post-traumatic stress disorder.
The Food and Drug Administration on Tuesday approved Rempex Pharmaceuticals' antibacterial drug Vabomere.
The FDA on Tuesday approved Chemo Research's Chagas drug for use in children ages 2 to 12.
Abbott Laboratories on Tuesday released a software update to boost cybersecurity protection for its pacemakers, reports StarTribune.